Treatment of urinary incontinence

Current Urology Reports

Volumn 1, Issue 3, 2000, Pages 235-244

  Rovner, Eric Scott ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Oxybutynin; Stress Urinary Incontinence; Tolterodine; Urge Incontinence; Urinary Incontinence

Indexed keywords

HUMAN; REVIEW; URINE INCONTINENCE; UROLOGIC SURGERY;

HUMANS; URINARY INCONTINENCE; UROLOGIC SURGICAL PROCEDURES;

EID: 0034308639     PISSN: 15272737     EISSN: 15346285     Source Type: Journal    
DOI: 10.1007/s11934-000-0024-2     Document Type: Article

References (71)

1. Berghmans LC, Hendriks HJ, Bo K, et al.: Conservative treatment of stress urinary incontinence in women: a systematic review of randomized clinical trials. Br J Urol 1998, 82:181–191.
2. Miller JM, Ashton-Miller JA, DeLancey JO: A pelvic muscle precontraction can reduce cough-related urine loss in selected women with mild SUI. J Am Geriatr Soc 1998, 46:870–874. This is an interesting paper that describes a technique termed the “knack” for the control of episodic SUI. For those patients with rare or isolated instances of SUI, this may be an effective treatment.
3. Bo K, Talseth T, Holme I: Single-blind, randomised controlled trial of pelvic floor exercises, electrical stimulation, vaginal cones, and no treatment in management of genuine stress incontinence in women. BMJ 1999, 318:487–493.
4. Wyman JF, Fantl JA, McClish DK, et al.: Comparative efficacy of behavioral interventions in the management of female urinary incontinence: Continence Program for Women Research Group. Am J Obstet Gynecol 1998, 179:999–1007. DOI: 10.1016/S0002-9378(98)70206-6
5. Galloway NT, El-Galley RE, Sand PK, et al.: Extracorporeal magnetic innervation therapy for stress urinary incontinence. Urology 1999, 53:1108–1111. A novel approach to the treatment of urinary incontinence, this completely noninvasive and apparently safe technique has numerous potential applications for the treatment of many types of voiding dysfunction. Further study is warranted to define the optimal treatment regimen and duration. DOI: 10.1016/S0090-4295(99)00037-0
6. Moore KH, Simons A, Dowell C, et al.: Efficacy and user acceptability of the urethral occlusive device in women with urinary incontinence. J Urol 1999, 162:464–468. DOI: 10.1016/S0022-5347(05)68592-8
7. Brubaker L, Harris T, Gleason D, et al.: The external urethral barrier for stress incontinence: a multicenter trial of safety and efficacy. Miniguard Investigators Group. Obstet Gynecol 1999, 93:932–937. DOI: 10.1016/S0029-7844(99)00251-3
8. Sander P, Thyssen H, Lose G, et al.: Effect of a vaginal device on quality of life with urinary stress incontinence. Obstet Gynecol 1999, 93:407–411. DOI: 10.1016/S0029-7844(98)00411-6
9. Bellin P, Smith J, Poll W, et al.: Results of a multicenter trial of the CapSure (Re/Stor) Continence shield on women with stress urinary incontinence. Urology 1998, 51:697–706. DOI: 10.1016/S0090-4295(98)00110-1
10. Davila GW, Neal D, Horbach N, et al.: A bladder-neck support prosthesis for women with stress and mixed incontinence. Obstet Gynecol 1999, 93:938–942. DOI: 10.1016/S0029-7844(99)00240-9
11. Moore KH, Foote A, Burton G, et al.: An open study of the bladder neck support prosthesis in genuine stress incontinence. Br J Obstet Gynaecol 1999, 106:42–49. The use of occlusive or supportive devices for the treatment of SUI often is limited by a number of factors. This study demonstrates that, despite the initial appeal of these devices as a noninvasive alternative to surgery, the number of patients who can be fitted and tolerate the device long-term is not great.
12. Tschopp PJ, Wesley-James T, Spekkens A, et al.: Collagen injections for urinary stress incontinence in a small urban urology practice: time to failure analysis of 99 cases. J Urol 1999, 162:779–782. DOI: 10.1097/00005392-199909010-00043
13. Gorton E, Stanton S, Monga A, et al.: Periurethral collagen injection: a long-term follow-up study. BJU Int 1999, 84:966–971. DOI: 10.1046/j.1464-410x.1999.00321.x
14. Corcos J, Fournier C: Periurethral collagen injection for the treatment of female stress urinary incontinence: 4-year follow-up results. Urology 1999, 54:815–818. DOI: 10.1016/S0090-4295(99)00269-1
15. Stenberg A, Larsson G, Johnson P, et al.: DiHA dextran copolymer, a new biocompatible material for endoscopic treatment of stress incontinent women: short-term results. Acta Obstet Gynecol Scand 1999, 78:436–442. DOI: 10.1034/j.1600-0412.1999.780517.x
16. Koelbl H, Saz V, Doerfler D, et al.: Transurethral injection of silicone microimplants for intrinsic urethral sphincter deficiency. Obstet Gynecol 1998, 92:332–336. DOI: 10.1016/S0029-7844(98)00215-4
17. Pycha A, Klingler CH, Haitel A, et al.: Implantable microballoons: an attractive alternative in the management of intrinsic sphincter deficiency. Eur Urol 1998, 33:469–475. DOI: 10.1159/000019637
18. Clemens JQ, Stern JA, Bushman WA, et al.: Long-term results of the Stamey bladder neck suspension: direct comparison with the Marshall-Marchetti-Krantz procedure. J Urol 1998, 160:372–376. DOI: 10.1016/S0022-5347(01)62898-2
19. Kondo A, Kato K, Gotoh M, et al.: The Stamey and Gittes procedures: long-term followup in relation to incontinence types and patient age. J Urol 1998, 160:756–758. DOI: 10.1016/S0022-5347(01)62778-2
20. Kuczyk MA, Klein S, Grünewald V, et al.: A questionnaire-based outcome analysis of the Stamey bladder neck suspension procedure for the treatment of urinary stress incontinence: the Hannover experience. Br J Urol 1998, 82:174–180.
21. Elkabir JJ, Mee AD: Long-term evaluation of the Gittes procedure for urinary stress incontinence. J Urol 1998, 159:1203–1205. DOI: 10.1016/S0022-5347(01)63556-0
22. Leach GE, Dmochowski RR, Appell RA, et al.: Female Stress Urinary Incontinence Clinical Guidelines Panel summary report on surgical management of female stress urinary incontinence: the American Urological Association. J Urol 1997, 158:875–880. This is the definitive work on the expected outcomes of SUI surgery. All surgeons who treat this condition should be familiar with this paper and be comfortable discussing it with their patients. DOI: 10.1016/S0022-5347(01)64346-5
23. Trockman BA, Leach GE, Hamilton J, et al.: Modified Pereyra bladder neck suspension: 10-year mean followup using outcomes analysis in 125 patients. J Urol 1995, 154:1841–1847. DOI: 10.1016/S0022-5347(01)66796-X
24. Chaikin DC, Rosenthal J, Blaivas JG: Pubovaginal fascial sling for all types of stress urinary incontinence: long-term analysis. J Urol 1998, 160:1312–1316. This is an important paper that reviews the long-term outcomes of pubovaginal sling in a complex group of patients. DOI: 10.1016/S0022-5347(01)62524-2
25. Cross CA, Cespedes RD, McGuire EJ: Our experience with pubovaginal slings in patients with stress urinary incontinence. J Urol 1998, 159:1195–1198. As the modern guru of the pubovaginal sling, Dr. McGuire and colleagues review their outcomes. In combination with the paper by Chaikin and Blaivas above, these results would be the best that one could expect using this technique. DOI: 10.1016/S0022-5347(01)63553-5
26. Choe JM, Staskin DR: Gore-Tex patch sling: 7 years later. Urology 1999, 54:641–646. DOI: 10.1016/S0090-4295(99)00190-9
27. Yamada T, Arai G, Masuda H, et al.: The correction of type 2 stress incontinence with a polytetrafluoroethylene patch sling: 5-year mean followup. J Urol 1998, 160:746–749. DOI: 10.1016/S0022-5347(01)62774-5
28. Ulmsten U, Johnson P, Rezapour M: A three-year follow up of tension free vaginal tape for surgical treatment of female stress urinary incontinence. Br J Obstet Gynaecol 1999, 106:345–350. The TVT procedure holds some promise as a minimally invasive technique for the treatment of SUI in the female; however, long-term data regarding safety and durability are necessary. This is not a procedure for those surgeons who are unfamiliar with or uncomfortable with transvaginal surgery.
29. Nilsson CG: The tensionfree vaginal tape procedure (TVT) for treatment of female urinary incontinence: a minimal invasive surgical procedure. Acta Obstet Gynecol Scand Suppl 1998, 168:34–37.
30. Ulmsten U, Falconer C, Johnson P, et al.: A multicenter study of tension-free vaginal tape (TVT) for surgical treatment of stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 1998, 9:210–213. DOI: 10.1007/BF01901606
31. Wang AC, Lo TS: Tension-free vaginal tape: a minimally invasive solution to stress urinary incontinence in women. J Reprod Med 1998, 43:429–434.
32. Wright EJ, Iselin CE, Carr LK, et al.: Pubovaginal sling using cadaveric allograft fascia for the treatment of intrinsic sphincter deficiency. J Urol 1998, 160:759–762. DOI: 10.1016/S0022-5347(01)62779-4
33. Nitahara KS, Aboseif S, Tanagho EA: Long-term results of colpocystourethropexy for persistent or recurrent stress urinary incontinence. J Urol 1999, 162:138–141. DOI: 10.1097/00005392-199907000-00034
34. Cardozo L, Hextall A, Bailey J, et al.: Colposuspension after previous failed incontinence surgery: a prospective observational study. Br J Obstet Gynaecol 1999, 106:340–344.
35. Maher C, Dwyer P, Carey M, et al.: The Burch colposuspension for recurrent urinary stress incontinence following retropubic continence surgery. Br J Obstet Gynaecol 1999, 106:719–724.
36. Saidi MH, Gallagher MS, Skop IP, et al.: Extraperitoneal laparoscopic colposuspension: short-term cure rate, complications, and duration of hospital stay in comparison with Burch colposuspension. Obstet Gynecol 1998, 92:619–621. DOI: 10.1016/S0029-7844(98)00266-X
37. McDougall EM, Heidorn CA, Portis AJ, et al.: Laparoscopic bladder neck suspension fails the test of time. J Urol 1999, 162:2078–2081. This is the first report of a large-scale trial demonstrating that the initial success of laparoscopic bladder neck suspension may not be as durable in the long term. DOI: 10.1016/S0022-5347(05)68105-0
38. FitzGerald MP, Gitelis S, Brubaker L: Pubic osteomyelitis and granuloma after bone anchor placement. Int Urogynecol J Pelvic Floor Dysfunct 1999, 10:346–348. DOI: 10.1007/s001929970014
39. Matkov TG, Hejna MJ, Coogan CL: Osteomyelitis as a complication of vesica percutaneous bladder neck suspension. J Urol 1998, 160:1427. DOI: 10.1016/S0022-5347(01)62560-6
40. Enzler M, Agins HJ, Kogan M, et al.: Osteomyelitis of the pubis following suspension of the neck of the bladder with use of bone anchors: a report of four cases. J Bone Joint Surg Am 1999, 81:1736–1740. This is a sobering reminder of the potentially devastating complications associated with the use of transvaginal bone anchors.
41. Vasavada SP, Rackley RR, Appell RA: In situ anterior vaginal wall sling formation with preservation of the endopelvic fascia for treatment of stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 1998, 9:379–384. DOI: 10.1007/BF02199569
42. Schultheiss D, Hofner K, Oelke M, et al.: Does bone anchor fixation improve the outcome of percutaneous bladder neck suspension in female stress urinary incontinence? Br J Urol 1998, 82:192–195.
43. Chaikin DC, Blaivas JG: Weakened cadaveric fascial sling: an unexpected cause of failure. J Urol 1998, 160:2151. DOI: 10.1016/S0022-5347(01)62268-7
44. FitzGerald MP, Mollenhauer J, Brubaker L: Failure of allograft suburethral slings. BJU Int 1999, 84:785–788. DOI: 10.1046/j.1464-410x.1999.00246.x
45. FitzGerald MP, Mollenhauer J, Bitterman P, et al.: Functional failure of fascia lata allografts. Am J Obstet Gynecol 1999, 181:1339–1344. Although it appears in some centers that fascia lata allografts are safe and durable, these authors report an unacceptably high failure rate with the use of this material. Whether the differences in failure rates are due to the processing of the graft material after harvesting is unclear. DOI: 10.1016/S0002-9378(99)70374-1
46. Kobashi KC, Dmochowski R, Mee SL, et al.: Erosion of woven polyester pubovaginal sling. J Urol 1999, 162:2070–2072. DOI: 10.1016/S0022-5347(05)68103-7
47. Goldman HB, Rackley RR, Appell RA: The efficacy of urethrolysis without re-suspension for iatrogenic urethral obstruction. J Urol 1999, 161:196–198. DOI: 10.1016/S0022-5347(01)62095-0
48. Petrou SP, Brown JA, Blaivas JG: Suprameatal transvaginal urethrolysis. J Urol 1999, 161:1268–1271. DOI: 10.1016/S0022-5347(01)61655-0
49. Stothers L, Goldenberg SL, Leone EF: Complications of periurethral collagen injection for stress urinary incontinence. J Urol 1998, 159:806–807. DOI: 10.1016/S0022-5347(01)63737-6
50. Simeonova Z, Milsom I, Kullendorff AM, et al.: The prevalence of urinary incontinence and its influence on the quality of life in women from an urban Swedish population. Acta Obstet Gynecol Scand 1999, 78:546–551. DOI: 10.1034/j.1600-0412.1999.780613.x
51. Visco AG, Weidner AC, Cundiff GW, et al.: Observed patient compliance with a structured outpatient bladder retraining program. Am J Obstet Gynecol 1999, 181:1392–1394. DOI: 10.1016/S0002-9378(99)70381-9
52. Burgio KL, Locher JL, Goode PS, et al.: Behavioral vs drug treatment for urge urinary incontinence in older women: a randomized controlled trial. JAMA 1998, 280:1995–2000. One of the best studies demonstrating the efficacy of behavioral therapy in the management of UUI: two thirds of patients responded. Clearly, when done correctly and consistently, pelvic floor exercise in the setting of behavioral modification is an effective treatment for UUI. DOI: 10.1001/jama.280.23.1995
53. Kelleher CJ, Cardozo LD, Khullar V, et al.: A medium-term analysis of the subjective efficacy of treatment for women with detrusor instability and low bladder compliance. Br J Obstet Gynaecol 1997, 104:988–993.
54. Nilvebrant L, Hallen B, Larsson G: Tolterodine—a new bladder selective muscarinic receptor antagonist: preclinical pharmacological and clinical data. Life Sci 1997, 60:1129–1136. DOI: 10.1016/S0024-3205(97)00057-X
55. Nilvebrant L, Andersson KE, Gillberg PG, et al.: Tolterodine—a new bladder-selective antimuscarinic agent. Eur J Pharmacol 1997, 327:195–207. DOI: 10.1016/S0014-2999(97)89661-6
56. Appell RA: Clinical efficacy and safety of tolterodine in the treatment of overactive bladder: a pooled analysis. Urology 1997, 50:90–96. DOI: 10.1016/S0090-4295(97)00599-2
57. Jonas U, Hofner K, Madersbacher H, et al.: Efficacy and safety of two doses of tolterodine versus placebo in patients with detrusor overactivity and symptoms of frequency, urge incontinence, and urgency: urodynamic evaluation. The International Study Group. World J Urol 1997, 15:144–151. DOI: 10.1007/BF02201987
58. Larsson G, Hallen B, Nilvebrant L: Tolterodine in the treatment of overactive bladder: analysis of the pooled phase II efficacy and safety data. Urology 1999, 53:990–998. DOI: 10.1016/S0090-4295(98)00629-3
59. van Kerrebroeck PE, Amarenco G, Thuroff, et al.: Dose-ranging study of tolterodine in patients with detrusor hyperreflexia. Neurourol Urodyn 1998, 17:499–512. DOI: 10.1002/(SICI)1520-6777(1998)17:5<499::AID-NAU6>3.0.CO;2-8
60. Rentzhog L, Stanton SL, Cardozo L, et al.: Efficacy and safety of tolterodine in patients with detrusor instability: a doseranging study. Br J Urol 1998, 81:42–48.
61. Abrams P, Freeman R, Anderstrom C, et al.: Tolterodine, a new antimuscarinic agent: as effective but better tolerated than oxybutynin in patients with an overactive bladder. Br J Urol 1998, 81:801–810.
62. Drutz HP, Appell RA, Gleason D, et al.: Clinical efficacy and safety of tolterodine compared to oxybutynin and placebo in patients with overactive bladder. Int Urogynecol J Pelvic Floor Dysfunct 1999, 10:283–289. DOI: 10.1007/s001929970003
63. Nilsson CG, Lukkari E, Haarala M, et al.: Comparison of a 10-mg controlled release oxybutynin tablet with a 5-mg oxybutynin tablet in urge incontinent patients. Neurourol Urodyn 1997, 16:533–542. DOI: 10.1002/(SICI)1520-6777(1997)16:6<533::AID-NAU3>3.0.CO;2-F
64. Gupta SK, Sathyan G: Pharmacokinetics of an oral once-a-day controlled-release oxybutynin formulation compared with immediate-release oxybutynin. J Clin Pharmacol 1999, 39:289–296.
65. Anderson RU, Mobley D, Blank B, et al.: Once daily controlled versus immediate release oxybutynin chloride for urge urinary incontinence: OROS Oxybutynin Study Group. J Urol 1999, 161:1809–1812. Equivalent efficacy was demonstrated between controlled-release and regular-release oxybutynin. DOI: 10.1016/S0022-5347(05)68810-6
66. Gleason DM, Susset J, White C, et al.: Evaluation of a new once-daily formulation of oxybutynin for the treatment of urinary urge incontinence: Ditropan XL Study Group. Urology 1999, 54:420–423. DOI: 10.1016/S0090-4295(99)00259-9
67. Awad SA, Al-Zahrani HM, Gajewski JB, et al.: Long-term results and complications of augmentation ileocystoplasty for idiopathic urge incontinence in women. Br J Urol 1998, 81:569–573.
68. Herschorn S, Hewitt RJ: Patient perspective of long-term outcome of augmentation cystoplasty for neurogenic bladder. Urology 1998, 52:672–678. DOI: 10.1016/S0090-4295(98)00220-9
69. Shaker HS, Hassouna M: Sacral nerve root neuromodulation: an effective treatment for refractory urge incontinence. J Urol 1998, 159:1516–1519. DOI: 10.1097/00005392-199805000-00028
70. Schmidt RA, Jonas U, Oleson KA, et al.: Sacral nerve stimulation for treatment of refractory urinary urge incontinence: Sacral Nerve Stimulation Study Group. J Urol 1999, 162:352–357. A well-done study demonstrating the utility and efficacy of neuromodulation in the treatment of UUI. DOI: 10.1016/S0022-5347(05)68558-8
71. Weil EH, Ruiz-Cerda JL, Eerdmans PH, et al.: Sacral root neuromodulation in the treatment of refractory urinary urge incontinence: a prospective randomized clinical trial. Eur Urol 2000, 37:161–171. DOI: 10.1159/000020134